Quality indicators for Palliative Day Services: A modified Delphi study by McCorry, Noleen et al.
For Peer Review
 
 
 
 
 
 
QUALITY INDICATORS FOR PALLIATIVE DAY SERVICES: A 
MODIFIED DELPHI STUDY 
 
 
Journal: Palliative Medicine 
Manuscript ID PMJ-18-0136.R1 
Manuscript Type: Original Article 
Date Submitted by the Author: 11-Sep-2018 
Complete List of Authors: McCorry, Noleen; Queen's University Belfast, Centre of Excellence for 
Public Health 
O'Connor, Sean; Ulster University, Institute of Nursing and Health 
Research 
Leemans, Kathleen; Ghent University & Vrije Universiteit Brussel (VUB), 
End of Life Care Research Group; Vrije Universiteit Brussel, Department of 
Radiotherapy 
Coast, Joanna; University of Bristol, School of Social and Community 
Medicine 
Donnelly, Michael; Queen's University Belfast, Centre of Excellence for 
Public Health 
Finucane, Anne; Marie Curie Hospice Edinburgh, Research 
Jones, Louise; Marie Curie Palliative Care Research Department, Division of 
Psychiatry, UCL 
Kernohan, George; Ulster University, Institute of Nursing and Health 
Research 
Perkins, Paul; Sue Ryder Care Leckhampton Court Hospice, Palliative 
Medicine; Gloucestershire Hospitals NHS Foundation Trust, Palliative 
Medicine 
Dempster, Martin; Queens University Belfast, Psychology 
Keywords: 
Quality Indicators, Delphi technique, Day services, Quality Improvement, 
Palliative care 
Abstract: 
Background: The goal of Palliative Day Services is to provide holistic care 
that contributes to the quality of life of people with life threatening-illness 
and their families. Quality indicators provide a means by which to describe, 
monitor and evaluate the quality of Palliative Day Services provision, and 
act as a starting point for quality improvement. However, currently, there 
are no published quality indicators for Palliative Day Services.  
Aim: To develop and provide the first set of quality indicators that describe 
and evaluate the quality of Palliative Day Services.  
Design and setting: A modified Delphi technique was used to combine best 
available research evidence derived from a systematic scoping review with 
multi-disciplinary expert appraisal of the appropriateness and feasibility of 
candidate indicators. The resulting indicators were compiled into ‘toolkit’, 
and tested in five UK Palliative Day Service settings.  
Results: A panel of experts independently reviewed evidence summaries 
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for 182 candidate indicators and provided ratings on appropriateness, 
followed by a panel discussion and further independent ratings of 
appropriateness, feasibility, and necessity. This exercise resulted in the 
identification of 30 indicators which were used in practice testing. The final 
indicator set comprised 7 structural indicators, 21 process indicators, and 2 
outcome indicators.  
Conclusions: The indicators fulfil a previously unmet need among Palliative 
Day Service providers by delivering an appropriate and feasible means to 
assess, review, and communicate the quality of care, and to identify areas 
for quality improvement.   
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ABSTRACT 
Background: The goal of Palliative Day Services is to provide holistic care that contributes to 
the quality of life of people with life threatening-illness and their families. Quality indicators 
provide a means by which to describe, monitor and evaluate the quality of Palliative Day 
Services provision, and act as a starting point for quality improvement. However, currently, 
there are no published quality indicators for Palliative Day Services. 
Aim: To develop and provide the first set of quality indicators that describe and evaluate the 
quality of Palliative Day Services. 
Design and setting: A modified Delphi technique was used to combine best available 
research evidence derived from a systematic scoping review with multi-disciplinary expert 
appraisal of the appropriateness and feasibility of candidate indicators. The resulting 
indicators were compiled into ‘toolkit’, and tested in five UK Palliative Day Service settings.  
Results: A panel of experts independently reviewed evidence summaries for 182 candidate 
indicators and provided ratings on appropriateness, followed by a panel discussion and 
further independent ratings of appropriateness, feasibility, and necessity. This exercise 
resulted in the identification of 30 indicators which were used in practice testing. The final 
indicator set comprised 7 structural indicators, 21 process indicators, and 2 outcome 
indicators. 
Conclusions: The indicators fulfil a previously unmet need among Palliative Day Service 
providers by delivering an appropriate and feasible means to assess, review, and 
communicate the quality of care, and to identify areas for quality improvement.   
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WHAT IS ALREADY KNOWN ABOUT THE TOPIC? 
• Measurement of health care quality creates the basis for quality improvement 
• Quality indicators can provide a valid and reliable means of measuring quality of care 
• There are currently no published quality indicators specifically for Palliative Day 
Services 
WHAT THIS PAPER ADDS 
• This paper describes the development of the first set of quality indicators specifically 
for quality improvement in Palliative Day Services 
• The final set comprises 7 structural indicators (e.g. ‘Service has a written standard 
operating procedure for dev lopment and use of multidisciplinary care plans’), 21 
process indicators (e.g. ‘Proportion of service users with assessment of pain severity 
at screening using a valid measure’), and 2 outcome indicators (e.g. ‘Proportion of 
service users re-assessed at regular review who report that main care goals are 
met’). 
IMPLICATIONS FOR PRACTICE, THEORY OR POLICY 
• The quality indicator set offers day service providers with a means of describing and 
reviewing the quality of their care, and providing feedback to stakeholders 
• Use of the indicator set in practice will allow providers to identify areas for quality 
improvement 
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INTRODUCTION 
Quality indicators are statements that define explicitly and in measurable terms the quality 
of a given construct or phenomenon. They provide a means with which to describe, monitor 
and evaluate healthcare.[1] Ideally, they should be evidence-based with a theoretical 
foundation such as Donabedian’s structure, processes and outcomes framework.[2] Quality 
indicators can provide service users, their families, care staff, providers, commissioners, 
purchasers, and inspectorates of care with data in relation to the quality of care, sometimes 
against benchmarks or previous quality assessments. In addition, by providing a valid and 
reliable means of measuring quality of care, quality indicators (although not sufficient by 
themselves) can act as a starting point for quality improvement.[3]
 
In the United Kingdom, as in many European countries, Palliative Day Services provide 
specialist palliative care within a group context for people with terminal or life-limiting 
illness, facilitated by a specialist multi-disciplinary team.[4] The goal of Palliative Day 
Services is to provide individualised, holistic care that promotes independence and 
rehabilitation, improves self-worth, and ultimately enables the best quality of life for 
patients and their families.[4,5] However, there is considerable variation within Palliative 
Day Services, and providers are under pressure to define and measure the quality of their 
services, identify areas for improvement and assess the impact of service development and 
improvement efforts. In order to address these issues, we developed the first set of quality 
indicators that are designed specifically for use by Palliative Day Services. We propose that 
our indicators be used to support services to evaluate care quality on an ongoing basis, to 
identify valid and appropriate goals for quality improvement.   
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METHODS AND RESULTS 
We used the RAND/UCLA appropriateness method[6] which has been incorporated into a 
comprehensive approach for the development of quality indicators in palliative care.[7] The 
RAND/UCLA appropriateness method is a modified Delphi method which combines the use 
of evidence with the collective judgement of experts, and is particularly suited to this area 
of healthcare because of the dearth of evidence related to day services. Expert panellists 
provide two rounds of independent ratings and have the opportunity to discuss their 
judgments between the rating rounds during a face-to-face meeting. The method has been 
shown to have a high level of reproducibility and validity.[6] Figure 1 shows the phases in 
the research process. 
The study protocol was approved by th  School of Psychology, Queen’s University Belfast 
Research Ethics Committee (ref: 10-2015-16) in September 2015. Expert panel members 
provided written informed consent to participate in the study. 
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Figure 1: Phases in the research process, including number of potential quality indicators 
identified at each stage.
 
  
Phase 3: Practice test (November 2016)
Practice test of draft (n=30) indicator set and data 
extraction toolkit in 5 UK day service settings
All 30 indicators retained. Minor rewording of 3 
indicators and toolkit instructions
RAND/UCLA method round 3 (May 2016)
Postal survey and review by research team 
and expert panel
Indicators combined/reworded
30 'core' indicators in draft set
RAND/UCLA method round 2 (December 2015)
Face-to-face panel discussion followed by further 
independent rating of appropriateness, feasibility 
and necessity by expert panel
56/112 indicators removed (11 inappropriate; 17 
unfeasible; 28 'supplementary')
56 indicators retained
Phase 2: RAND/UCLA method round 1 (November 2015)
Independent appropriateness ratings of candidate 
indicators by expert panel using postal survey
70/182 indicators rated as inappropriate 
112 appropriate indicators
Phase 1: Systematic scoping review (May - August 2015)
Systematic scoping review to collate (1) potential 
quality indicators, and (2) domains of care
182 candidate indicators identified, with evidence 
summaries, categorised under 17 domains
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Phase 1 – A systematic scoping review to identify existing quality indicators and domains 
A systematic scoping review was conducted to identify existing quality indicators in all areas 
of palliative care, and other evidence or recommendations which might inform the 
development of (or translation of evidence into) a quality indicator, i.e. structural or process 
level variables which have been shown to be related to outcomes of care. Any domains / 
themes used to describe the indicators were also identified. Established frameworks were 
used to guide the review protocol,[8,9] which is published elsewhere.[10] 
 This review resulted in the identification of 182 unique candidate indicators (supplementary 
file 1) and 17 care domains. Evidence tables summarising the content, sources and quality of 
evidence (using AIRE[11] and GRADE[12] scores where appropriate) of quality indicators 
represented in each domain were compiled.  
Phase 2 - Quality indicator selection by expert consultation following the internationally 
validated RAND (Research ANd Development) / UCLA (University of California, Los 
Angeles) Appropriateness Method (RAM) 
Round 1 – Expert panel questionnaire 
A multidisciplinary panel of individuals with expertise in Palliative Day Services was 
established. A total of 58 potential panel members were directly approached 
(recommended by the research team) or responded to advertisements. We selected experts 
based on their experience and expertise in the area of Palliative Day Services, while aiming 
for diversity in geographical representation and professional specialism. Panel members 
were asked to commit 21 hours to the project over 3 months. The resultant panel consisted 
of 21 individuals from across the United Kingdom, including palliative care consultants, 
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specialist nurses, day service and hospice managers, allied health professionals, spiritual 
care providers, a social worker, a complementary therapist, a psychologist and a 
pharmacist. Several panellists had experience of more than one day service model and 
previous experience of consensus development methods. Panel members were sent a 
document pack including general information about quality indicators and their properties 
(including a description of Donabedian’s model)[2], a series of evidence tables for candidate 
quality indicators, a rating booklet, and a short commentary from Marie Curie (a major UK 
palliative care provider) endorsing the project objectives. All materials were reviewed by the 
research team and two user representatives. 
Panellists were asked to independently rate the appropriateness of each quality indicator on 
a 9-point scale (according to the RAND/UCLA method[6] method) where an appropriate 
indicator (rated 7-9) was defined as one which was acceptable and likely to represent a 
reasonable measure of quality in Palliative Day Services. Alternatively, an inappropriate 
indicator (rated 1-3) was defined as one which should rarely or never be used as a measure 
of quality in Palliative Day Services, and where any re-wording or reframing of the indicator 
would not alter this assessment. Ratings of 4-6 represented indicators which were thought 
to be neither appropriate nor inappropriate. Panellists were asked to base ratings on their 
own knowledge and experience, as well as the evidence summary tables provided, but not 
to rate appropriateness based on the cost implications associated with a particular 
indicator. It was explained to panellists that although cost consideration is an important 
factor in deciding whether a particular procedure or treatment is ultimately made available 
to patients, the RAM focuses only on the initial question of whether it is effective. Panellists 
were also asked to suggest additional quality indicators, and to review and provide feedback 
on the proposed quality domains. The indicator ratings were subsequently analysed based 
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on their median appropriateness scores and the level of agreement between panel 
members using the criteria specified by the RAND/UCLA appropriateness method.[6] 
Indicators with a median appropriateness rating of 3 or less (inappropriate) and good 
agreement on this rating by the panel, were highlighted for exclusion.  
Twenty panellists returned round 1 ratings. Round 1 resulted in the identification of 70 
inappropriate indicators and 112 candidate appropriate or uncertain indicators. 
Round 2 – Expert panel meeting 
All panellists who participated in round 1 were invited to attend a one day, face-to-face 
meeting, where the analysis of round 1 ratings was presented. The meeting was moderated 
by a health psychologist (MDe) with extensive experience in facilitating group discussion, 
and was attended by 12 panellists. The aims of the meeting were to: 
1) confirm the exclusion of indicators rated as inappropriate as a result of round 1 ratings, 
2) discuss those indicators for which, following round 1, appropriateness was uncertain  
3) discuss indicators for which appropriateness was acceptable but there was 
disagreement between panellists and 
4) review the terminology used in indicator descriptions  
Following the discussions, panellists were asked to independently re-rate the 
appropriateness of the 112 indicators. Panel members agreed that the indicator set should 
be designed and promoted as a tool to support the assessment of quality in a formative 
manner, and the identification of quality improvement goals, and not as a means of 
comparison between services or for inspection purposes - which would require more 
detailed consideration of risk adjustments. At this stage, panel members were also asked to 
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independently rate the feasibility of measuring each indicator in the day service setting 
using the same 9-point scale, and to assess if each indicator was a necessary measure 
(yes/no response). A necessary measure was defined as: appropriate; likely to benefit the 
patient; that the benefit is not small; and where it would be improper care not to offer the 
procedure under review.[6] The same criteria as round 1 were used to remove inappropriate 
indicators. In addition, only quality indicators with a median feasibility rating of 4 or greater 
(with good agreement) were retained. The categorisation of necessity was used to produce 
a list of core and supplementary indicators. Indicators were defined as supplementary if less 
than half the panel identified the indicators as a necessary measure.  
As a result of round 2 ratings, 11 indicators were agreed to be inappropriate, and 17 were 
unfeasible. A further 28 indicators were removed based on the assessment of necessity. 
Hence 56 core indicators (agreed to be appropriate, feasible and necessary) were retained 
following round 2. Supplementary file 1 shows the decisions during rounds 1 and 2.  
Round 3 – Second panel questionnaire 
The set of 56 core indicators were then reviewed by the research team and expert panel 
members (with a particular focus on wording and duplication) who were sent the indicator 
set by email. 
Round 3 resulted in the rewording or combination of 41 indicators, and hence a 
consolidated set of 30 unique indicators. Supplementary file 2 shows the derivation of the 
draft indicator set from the original 182 candidate indicators. This draft indicator set 
included 7 structural indicators, 21 process indicators and 2 outcome indicators, categorised 
under 10 domains of care. There were most quality indicators (n=9) representing the 
domain ‘co-ordination and continuity of care’. For 24 of the indicators, the focus is on 
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patient or staff interaction with the service (eg. ‘Proportion of service users with assessment 
of pain severity at screening using a valid measure’ (#A1)), while 6 indicators represented 
service characteristics (eg. ‘Service has a written care pathway for assessment and 
management of moderate or severe pain including appropriate onward referral routes’ 
(#E12)).  
Phase 3 - Testing the draft quality indicator set in practice 
The draft indicator set was compiled into a toolkit with detailed descriptions of each quality 
indicator (including the numerator, denominator and definitions), and instructions to assist 
with the extraction of relevant data. Supplementary file 3 is an extract from the toolkit. The 
indicator set and toolkit was then field-tested in 5 UK Palliative Day Service settings, in 
England (2), Scotland (1) and Northern Ireland (2) representing 3 different palliative care 
providers. The toolkit instructed data abstractors to assess performance on each quality 
indicator using paper-based or electronic records for 15 consecutive patients discharged 
from the Palliative Day Service in the previous 12 months (for patient level indicators), and 
any relevant accessible documentation including service policies and procedures (for service 
level indicators). Day service managers at each site completed the data abstraction. 
Abstractors were asked to ‘think aloud’[13] while completing the paperwork – so that 
challenges or misunderstandings could be readily identified by the researcher, who was 
available during the entire abstraction process.  
In total, data were extracted from 82 patient records. Following completion of the practice 
test, the rate and variation in the proportion of patients/staff for whom each quality 
indicator was met, and the proportion of settings which satisfied the service level indicators 
was compiled (supplementary file 4). Overall, there was considerable variation across the 5 
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services in performance against the indicators, particularly for assessment of patient 
satisfaction, recording of care goals, and completion of care plans. The indicators that were 
least likely to be met were concerned with quality of life assessment, availability of a 
completed multidisciplinary care plan, and assessment of patient satisfaction with support 
for decision making, with some services not collecting any information on patient 
satisfaction or quality of life. The indicators that were most likely to be met were concerned 
with the documentation of: time from referral to first attendance date offered; informed 
consent to treatment or medical intervention; and communication between the service and 
the General Practitioner providing information on care needs and care plans. Feedback from 
data abstractors indicated that: 
• Data abstraction was perceived as time consuming 
• Abstractors had to refer to several different sources of information  
• The paper-based extraction forms added to the cumbersome nature of the process 
• Data abstractors were not confident about the process for calculation of each 
indicator 
As a result of the practice test minor amendments were made to three of the indicators, 
and to the toolkit instructions. Table 1 shows the final (QualPalUK) quality indicator set. 
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Table 1: Final QualPalUK quality indicator set (n=30), following phase 3 of the RAND/UCLA Appropriateness Method    
 
 Indicator description, categorised by care domain 
    
Indicator 
type* 
 A. Physical care and support, assessment and treatment   
A1 Proportion of service users with assessment of pain severity at screening using a valid measure   P 
A2 Proportion of service users with moderate or severe pain assessed to explore possible causes of pain   P 
A3 Proportion of service users with assessment of breathlessness at screening using a valid measure  P 
A4 Proportion of service users with assessment of fatigue at screening using a valid measure  P 
A5 Proportion of service users with assessment of functional status to identify daily activity limitations completed 
before a multidisciplinary care plan   
P 
 B. Psychological care and support, assessment and treatment  
B6 Proportion of service users screened for depression at screening using a valid measure   P 
B7 Proportion of service users screened for anxiety at screening using a valid measure   P 
B8 Proportion of service users with assessment of cognitive functioning  P 
 C. Spiritual and emotional care and support  
C9 Proportion of service users with documentation of a ‘spiritual aspects of care discussion or assessment’ completed 
before a multidisciplinary care plan      
P 
 D. Information and Communication with Service Users  
D10 Proportion of service users who report that they are provided with sufficient, appropriately tailored information or 
advice on their condition and on intervention options to support decisions on agreed care planning 
O 
 E. Co-ordination and continuity of care  
E11 Proportion of service users with a comprehensive needs assessment completed before a multidisciplinary care 
plan to identify main symptoms and concerns, and their effect     
P 
E12 Service has a written care pathway for assessment and management of moderate or severe pain including 
appropriate onward referral routes 
S 
E13 Proportion of service users with documentation of re-assessment at regular review in line with time points agreed 
in the multidisciplinary care plan 
P 
E14 Service has written standard operating procedures defining timeframes for time to initial contact, completion of 
needs assessment and multidisciplinary care plan 
S 
E15 Proportion of service users with documentation of appropriate intervention in line with the agreed, multidisciplinary 
care plan      
P 
E16 Proportion of service users with documented communication between the service & the General Practitioner 
providing information on care needs and care plans   
P 
E17 Proportion of service users with a care plan available as specified by the service’s written standard operating P 
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procedure for development and usage of multidisciplinary care plans 
E18 Proportion of service users with documented evidence of being offered the opportunity for completion of advance 
care planning   
P 
E19 Proportion of service users with quality of life assessed using a valid measure at screening and at regular review in 
line with time points agreed in the multidisciplinary care plan   
P 
 F. Care planning, goal setting and shared decision making with service users  
F20 Service has a written standard operating procedure for development and use of multidisciplinary care plans S 
F21 Proportion of service users with documentation of main care goals in the multidisciplinary care plan                                    P 
 G. Evidence of effectiveness, outcome assessment and measurement  
G22 Service has a written policy for reviewing and updating standard operating procedures and care pathways S 
G23 Proportion of service users re-assessed at regular review who report that main care goals are met in line with the 
multidisciplinary care plan 
O 
G24 
 
G25 
Proportion of service users with assessment of satisfaction with overall care and support performed using a valid 
measure 
Proportion of service users with assessment of satisfaction with involvement in shared decision making    
P 
 
P 
 H. Staff training and education, service and professional development  
H26 Extent to which staff have access to training around core components of care as part of continuing education and 
personal development 
S 
 I. Access to services and service environment  
I27 Proportion of service users with a record of time in days from referral date to first attendance date offered by 
service  
P 
I28 The service provides suitable equipment and settings to deliver care S 
I29 Service has a written policy for defining standards for equipment and settings which are available for delivery of 
care 
S 
 J. Societal, ethical and legal aspects of care  
J30 Proportion of service users with correctly completed documentation of informed consent to treatment or medical 
intervention    
P 
*Indicator type: S: Structure; P: Process; O: Outcome 
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DISCUSSION 
Results of the study 
We have developed the first set of quality indicators specifically for use in Palliative Day 
Services, using a recommended, evidence based approach[7]. The indicators were derived 
from a comprehensive review of the international literature. The full set of original 182 
indicators are provided as a resource in supplementary material and can be used to make 
adjustments for jurisdictions outside the UK if necessary. The final indicator set (reflecting 
Donebedian’s model)[2] contains 2 outcome, 21 process, and 7 structural indicators, across 
10 domains of care. The limited number of outcome indicators is a result of the expert 
panel’s preference to incorporate patient reported outcome measurement (in relation to 
the assessment of pain, breathlessness, fatigue, functional status, depression, anxiety, and 
quality of life) into relevant process and structural indicators, and to avoid the complex 
adjustment and exclusions often associated with the quality appraisal using outcome 
indicators[14-19]. For example, rather than measure absolute ‘pain intensity’ or ‘change in 
pain intensity’ (both outcome indicators), the panel preferred to measure the extent to 
which patients had their pain measured using a validated instrument (#A1 and #A2- both 
process indicators), and the extent to which valid pathways were in place to manage the 
individual patient’s pain (E12 – a structural indicator).  This approach still incorporates the 
perspective of the service user in the process of quality assessment,[20,21] but requires that 
staff solicit these patient reported outcomes routinely and use them effectively to meet 
patient needs. Clearly however, both structural and process level quality indicators are only 
valid assessments of quality of care if they can be shown to increase the likelihood of a good 
outcome,[22] and hence the evidence base should be reviewed regularly to identify these 
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relationships. The panel did, however, endorse outcome indicators in relation to service 
users’ satisfaction with information and advice received (#D10) and whether service users 
reported that their main care goals had been met (#G23). 
One characteristic of a ‘good quality indicator’ is the extent to which the quality indicator 
refers to an aspect of care which can be influenced by the players being evaluated[23]. 
Many quality indicators developed more recently[7,24,25,26] have been proposed to be 
relevant to a range of different palliative care services. It is inevitable though that some of 
the indicators within these sets will not be within the control of those care personnel 
associated with the service being evaluated. Several authors have commented on this ‘fit’ 
between the indicator set and the service being evaluated[27,28] and have recommended 
that indicators be amended or removed as appropriate. We believe that the specificity of 
our indicator set is a significant advantage as it means the indicator set is immediately 
accessible to UK Palliative Day Services, without modification. There is considerable scope 
for international collaboration in the development of quality indicators,[29,30] and hence 
with appropriate modifications to account for contextual and cultural differences, our 
indicator set will be valuable in other PDS services, internationally. The original set of 182 
unique PDS quality indicators (supplementary file 2) derived from a comprehensive review 
of the international literature is a valuable reference for other providers wishing to develop 
PDS quality indicators. 
Implementation in practice 
The value of quality indicators is fully realised when they are implemented in routine 
practice, and used as a basis for quality improvement. Fifteen years after the Council of 
Europe first encouraged the definition and adoption of quality indicators of good palliative 
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care, there is still little evidence of widespread implementation in practice.[16,31,32] Some 
of the barriers to successful implementation of quality indicators in palliative care settings 
include the attitudes towards quality improvement within the organisation[27] and among 
staff,[28] the perceived value of quality indicators,[27,28] and ‘top-down’ engagement[27].  
Drawing upon this evidence and the improvement science literature,[33] we have 
incorporated features in our research design which are intended to improve the likelihood 
of uptake and implementation by Palliative Day Services. Use of the rigorous RAND/UCLA 
method results in a set of indicators with high face and content validity.[34-36] We have 
enhanced the perceived acceptability and credibility of the indicator set by promoting 
stakeholder awareness and involvement in the development of the indicators, and by 
ensuring representation on our expert panel from services where we wish the indicators to 
be utilised. We have communicated widely (via newsletters, presentations, the QualPalUK 
website, and site visits) about the development process, and have provided opportunities 
for stakeholder feedback. However, for successful implementation we will also need to be 
attuned to variations in current practice, the range of measures already in place in care 
settings, the diversity of systems (including IT systems), and staff training.[28,37]  
Assessment of care quality is agreed to be an essential element of service provision, and the 
quality indicator set is a comprehensive and evidence based tool that enables this process. 
This comprehensive assessment requires time investment by services that are often time-
poor, on an annual or bi-annual basis. Implementation will be facilitated where: services are 
able to organise their routinely collected data in a manner that is easily accessible for data 
extractors; service personnel recognise the direct impact of quality assessment on service 
improvements; data extractors become more familiar with use of the tool; and where 
efficiency of data extraction is enhanced via electronic capture.  We are now developing an 
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electronic version of the quality indicator toolkit which will help to reduce the time required 
for data extraction and calculation of the quality indicators by allowing abstractors to input 
the required (prompted) fields, with calculations completed by the programme in the 
background. We will supplement the quality indicator toolkit with a quality improvement 
module which will support Palliative Day Services to first identify areas for quality 
improvement, and subsequently to use Plan-Do-Study-Act cycles[38] to work towards 
improvement.  
Although there were only five practice sites, the practice test indicated that the assessment 
of satisfaction and quality of life, and the production (and communication of) 
comprehensive care plans and needs assessments are areas which may require attention 
within Palliative Day Services. This finding is consistent with existing literature which has 
demonstrated that, despite initiatives promoting the routine measurement of patient 
reported outcomes,[39-42], and strong evidence of a positive effect on a multitude of care 
outcomes (including patient-clinician communication, patient satisfaction, and identification 
of unrecognized symptoms),[43] they are not yet widely measured in palliative care 
practice. Failure to implement patient reported outcome measurement in palliative care has 
been attributed to barriers including fear of change, time management/ constraints, lack of 
education on use of tools, burden of tools for staff and service users, illness severity, 
concerns about criticism, and cost constraints.[44] The assessment of patient reported 
outcomes is therefore one area where quality improvement projects may be particularly 
productive and valued by the Palliative Day Services community. In contrast, indicators 
which utilise administrative data that maps onto the requirements of national[45] or 
internal organisational audits were more likely to be met, such as ‘time from referral to first 
attendance’, or ‘consent to treatment’. 
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Strengths and weaknesses 
The RAND/UCLA method has been shown to produce indicators with high content[34,46] 
and predictive validity.[32,47,48] However, these characteristics and others (including 
sensitivity to change and reliability) should be field tested in a larger representative sample 
of Palliative Day Services, using the electronic toolkit for data extraction. In addition, the 
time commitment required from Delphi panellists often results in a panel that is atypical 
with respect to their interest and commitment to the topic being investigated. Generating 
interest in the value and implementation of PDS quality indicators more widely is likely to be 
challenging. 
What this study adds 
Our quality indicator set fulfils a need within the Palliative Day Services community, by 
providing a means of assessing and reviewing quality of care and identifying areas for 
improvement.  
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Supplementary file 1: Original 182 candidate indicators, and panel ratings during round one and two of the RAND/UCLA Appropriateness Method (RAM)   
 
# Potential quality indicator descriptions Round 1 Round 2  
Core or 
supplementary 
indicator 
  
 
 
 
Care Domains 
Median 
Appropriateness 
Score/9 (Range)*  
Agreement 
between 
panel Y/N† 
    
Median 
Appropriateness 
Score/9 
 (Range) ‡ 
Median 
Feasibility 
Score/9§ 
  
Rated as 
necessary by 
panel  Y/N (% 
yes)¶ 
 Physical care and support, assessment and treatment       
DQI#01 Number of patients screened for pain using a validated measure  8 (5) Y 8.5 (3)    8 Y (100) Core  
DQI#02 Number of patients with a score >x/10 on a NRS/VAS (average 
pain on a typical day over the last week)  
3 (8) N - - - -  
DQI#03 Number of patients with moderate to severe pain 7 (8) Y 7 (5) 5.5 Y (55) Core  
DQI#04 For patients who screen positive for pain, the number with any 
treatment within [x] week[s]   
7 (4) Y 8 (3) 7.5 N (36) Supplementary  
DQI#05 For patients who screen positive for pain, the number with 
significant improvement after [x] week[s]  
5.5 (7) N 4.5 (4) 2 N (45) -  
DQI#06 Number of patients assessed to identify likely cause of pain 
based on site and radiation (e.g. using a body diagram) 
7 (3) Y 8 (3) 8 N (27) Supplementary  
DQI#07 Number of patients assessed to identify likely cause of pain 
based on character (e.g. using a list of descriptors) 
9 (3) Y 7.5 (3) 7.5 N (27) Supplementary  
DQI#08 Number of patients assessed to identify likely cause of pain 
based on exacerbating/relieving factors including analgesics 
8.5 (3) Y 8 (3) 8 N (27) Supplementary  
DQI#09 Number of patients assessed to identify likely cause of pain 
based on timing and duration  
7.5 (3) Y 7 (4) 7.5 N (27) Supplementary  
DQI#10 Number of patients assessed to identify likely cause of pain 
based on effect on function, sleep and mood 
9 (2) Y 7.5 (2) 8 Y (55) Core  
DQI#11 Documentation of other factors (e.g. emotional, psychological or 
spiritual) with possible effect on pain perception 
4 (5) Y 4.5 (3) 4.5 Y (55) Core  
DQI#12 Number of patients screened for SOB using a validated measure 7 (3) Y 8 (4) 5.5 N (57) Core 
DQI#13 For patients who screen positive for SOB, the number with any 
treatment within [x] week[s]   
5 (4) Y 3.5 (4) 7 N (36)  Supplementary  
DQI#14 For patients who screen positive for SOB, the number with 
significant improvement after [x] week[s] 
3.5 (4) Y 7 (3) 8 N (64)  Core 
DQI#15 Number of patients screened for upper GI (stomach) problems 
(nausea/vomiting) using a validated measure 
6 (5)  Y 4 (2) 5.5 N (18) Supplementary 
DQI#16 For patients who screen positive for upper GI problems, the 
number with any treatment within [x] week[s]  
8 (3) Y 8 (3) 8 N (45) Supplementary 
DQI#17 For patients who screen positive for upper GI problems, the 
number with significant improvement after [x] week[s]      
7 (5) N 4.5 (3) 3 N (9) - 
DQI#18 Number of patients screened for lower GI (abdominal) problems 
(constipation) using a validated measure 
7 (4) Y 7.5 (3) 6 Y (55) Core 
DQI#19 For patients who screen positive for lower GI problems, the 
number with any treatment within [x] week[s]   
7 (3) Y 5.5 (2) 7.5 Y (55) Core  
DQI#20 For patients who screen positive for lower GI problems, the 
number with significant improvement after [x] week[s] 
9 (2) Y 5 (5) 2 N (27) - 
DQI#21 Number of patients screened for poor mobility using a validated 
measure 
6.5 (2) Y 3.5 (2) 7.5 N (45) Supplementary  
DQI#22 For patients who screen positive for poor mobility, the number 
with any treatment within [x] week[s]   
6 (8) N 5.5 (3) 1.5 N (27) - 
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DQI#23 For patients who screen positive for poor mobility, the number 
with significant improvement after [x] week[s] 
3 (5) N 4.5 (3) 2 N (27) - 
DQI#24 Number of patients screened for tiredness/weakness  8 (3) Y 8 (3) 8 Y (55) Core  
DQI#25 For patients who screen positive for tiredness/weakness, the 
number with any treatment within [x] week[s]   
4 (5) N 5.5 (3) 3 N (36) - 
DQI#26 For patients who screen positive for tiredness/weakness, the 
number with significant improvement after [x] week[s] 
5.5 (3) Y 3.5 (4)  5.5 Y (73) Core 
DQI#27 Number of patients screened for insomnia using a validated 
measure 
3 (6) N - - - - 
DQI#28 For patients who screen positive for insomnia, the number with 
any treatment within [x] week[s] 
3 (4) Y - - - - 
DQI#29 For patients who screen positive for insomnia, the number with 
significant improvement after [x] week[s]  
3 (4) Y 4 5 Y (55) Core 
DQI#30 Number of patients with an assessment of functional status made 
using a validated measure reviewed within a [x] month period 
9 (3) Y 7 (3) 5.5 Y (64) Core 
DQI#31 Number of patients screened for general symptom assessment 
using a validated measure and reviewed within a [x] month 
period  
9 (3) Y 8 (4) 8 Y (91) Core 
DQI#32 Number of patients with a symptom management plan, including 
goals, agreed in conjunction with the patient and family 
9 (3) Y 7.5 (4) 7.5 Y (100) Core 
DQI#33 Number of patients with agreed arrangements for regular review 
of symptoms 
9 (3) Y 7 (5) 7.5 Y (73) Core 
DQI#34 Number of patients provided with written advice on physical 
symptom management 
5 (5) Y 4 (5) 2 N (27) - 
DQI#35 Number of patients who receive an individualized assessment of 
physical activity levels  
3 (7) Y - - - - 
DQI#36 Number of patients with an assessment made of satisfaction with 
overall physical care and support  
8 (2) Y 7.5 (3) 8 Y (55) Core  
DQI#37 Number of patients satisfied with overall physical care and 
support assessed using a standardized measure 
3 (8) Y - - - - 
 Psychological care and support, assessment and treatment       
DQI#38 Number of patients screened for depression using a validated 
measure within a [x] month period 
9 (2) Y 7.5 (3) 8 Y (55) Core 
DQI#39 Number of patients who screen positive for depression, the 
number with any treatment within [x] week[s]   
5 (6) N 6.5 (3) 4 Y (55) Core 
DQI#40 Number of patients who screen positive for depression, the 
number with significant improvement after [x] week[s]  
7 (4) Y 8 (4) 5.5 Y (55) Core 
DQI#41 Number of patients screened for anxiety using a validated 
measure within a [x] month period   
9 (1) Y 8 (3) 7.5 Y (91) Core 
DQI#42 Number of patients who screen positive for anxiety, the number 
with any treatment within [x] week[s]  
5 (4) Y 5.5 (2) 6 N (27) Supplementary 
DQI#43 Number of patients who screen positive for anxiety, the number 
with significant improvement after [x] week[s] 
7 (3) Y 7 (3) 2 Y (55) - 
DQI#44 Number of patients who receive support when they feel anxious 
or feel depressed  
3 (7) N - - - - 
DQI#45 Number of patients diagnosed with depression with a 
documented treatment plan 
8.5 (2) Y 6 (3) 8.5 Y (64) Core 
DQI#46 Number of patients diagnosed with depression with response to 
therapy documented within [x] week[s]  
3 (7) N - - - - 
DQI#47 Number of patients who receive adequate attention from their 1 (8) N - - - - 
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caregivers  
DQI#48 Number of patients are satisfied with the counselling aspects of 
“politeness” and “being taken seriously” 
1 (7) N - - - - 
DQI#49 Number of patients who experience respect for their autonomy  2.5 (8) N - - - - 
DQI#50 Number of patients who experience respect for their privacy 2 (4) Y - - - - 
DQI#51 Number of patients who receive overall quality of life assessment 
using a validated measure 
9 (3) Y 8 (2) 7.5 Y (100) Core 
DQI#52 Number of patients who receive condition specific psychological 
assessment using a validated measure 
1 (8) N - - - - 
DQI#53 Number of patients referred to / receiving stress management 
program or intervention 
1.5 (8) N - - - - 
DQI#54 Number of patients who receive treatment for psychological 
symptoms in a timely, safe and effective manner  
5 (6) N 6 (4) 6.5 N (27) Supplementary 
DQI#55 Number of patients with an assessment of cognition performed 
and results reviewed at least [x] times within [x] months 
9 (2) Y 4.5 (3) 7.5 Y (64) Core 
DQI#56 Number of patients with neuropsychiatric symptoms receiving or 
recommended to receive intervention within a [x] month period  
1 (8) N - - - - 
  Social care, assessment and management         
DQI#57 Number of patients with a comprehensive social care plan 
addressing social, practical, and legal needs of patient and 
caregivers  
1.5 (6) N - - - - 
DQI#58 Number of patients with equity of access to support for social 
care needs including counselling services  
1.5 (8) N - - - - 
DQI#59 Number of patients with a comprehensive interdisciplinary 
assessment identifying social needs of patients and families 
9 (2) Y 8 (3) 8 Y (82) Core 
DQI#60 Number of patients with an assigned professional who maintains 
contact to ensure co-ordinated delivery of services 
6 (5) N 5.5 (4) 4 N (18) Supplementary 
 Spiritual and emotional care and support         
DQI#61 Number of patients who indicate that caregivers respect their life 
stance 
1 (8) N - - - - 
DQI#62 Number of patients who indicate that they have access to a 
counsellor for spiritual problems  
3 (7) N - - - - 
DQI#63 Number of relatives who indicate that the patient had access to a 
counsellor for spiritual problems  
1 (8) N - - - - 
DQI#64 Number of relatives who indicate that the patient had accepted 
her/his approaching death 
1 (8) N - - - - 
DQI#65 Number of relatives who indicate that there was attention and 
respect for the spiritual well-being of the patient  
5 (4) Y 2 (3)  1.5 N (9) - 
DQI#66 Number of relatives who indicate that the patient had access to a 
counsellor for spiritual problems  
1 (8) N - - - - 
DQI#67 Number of patients who indicate that they feel that life is 
worthwhile 
1 (8) N - - - - 
DQI#68 Number of patients with documentation of discussion of 
spiritual/religious concerns or that the patient did not want to 
discuss 
9 (3) Y 6 (2) 8  Y (82) Core 
DQI#69 Number of patients with a plan based on an assessment of 
religious, spiritual, and existential concerns using a structured 
instrument 
9 (4) Y 4 (3) 8  Y (64) Core 
DQI#70 Number of patients with information about the availability of 
spiritual care services 
8 (4) Y 6 (4) 8  Y (91) Core 
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DQI#71 Number of patients assessed to identify important spiritual and 
emotional aspects of care using a validated measure  
6 (4) Y 4 (2) 6.5  Y (73) Core 
 Cultural aspects of care       
DQI#72 Number of patients with a non-English native language who have 
baseline screening performed in their native language 
4.5 (5) N 5 (4) 2 N (9) - 
DQI#73 Number of patients with access to translators where caregivers 
and patient / family members do not speak the same language 
8.5 (2) Y 7 (3) 2.5 Y (64) - 
DQI#74 Number of patients with a cultural assessment including 
preferences regarding disclosure of information and desire for 
support measures  
3 (7) N - - - - 
DQI#75 Number of patients provided with culturally sensitive materials in 
the patient’s and family’s preferred language 
9 (2) Y 5 (6) 2 Y (55) - 
 Generic aspects of care and health promotion       
DQI#76 Extent to which staff assess and manage symptoms and side 
effects in a timely, safe, and effective manner  
8 (1) Y 8 (3) 7.5 Y (64) Core 
DQI#77 Number of patients with documented communication between 
Day Service and General Practitioner   
9 (2) Y 8 (4) 8 Y (100) Core 
DQI#78 Extent to which patients receive information about the expected 
course of the illness 
1 (8) N - - - - 
DQI#79 Extent to which patients receive information about the 
advantages and disadvantages of various types of treatments 
2.5 (8) N - - - - 
DQI#80 Extent to which the distinct care needs of patients with different 
conditions are recognised and addressed 
2 (8) N - - - - 
DQI#81 Number of patients who receive individual or group patient self-
management 
2 (8)  N - - - - 
DQI#82 Number of exercise / rehabilitation sessions attended by patient 1 (8) N - - - - 
DQI#83 Number of patients or their caregiver(s) referred for counselling 
regarding safety concerns within an [x] month period 
1 (8) N - - - - 
DQI#84 Number of patients provided with education on disease 
management or referred to additional resources of support  
1 (8) N - - - - 
DQI#85 Number of patients with assessment and appropriate 
management of sexual dysfunction 
8 (6) N 7 (2) 8 Y (52) Core 
DQI#86 Extent to which patients experience respect for their autonomy / 
privacy   
6 (3) Y 4 (4) 7 N (36) Supplementary 
DQI#87 Number of patients assessed screened at least once to detect 
whether they use tobacco regularly  
1 (8) N - - - - 
DQI#88 Number of patients with an inventory of complaints and problems 1 (8) N - - - - 
DQI#89 Number of patients assessed to detect problem drinking by 
taking a history of alcohol use or using standardized screening 
questionnaires 
1 (8) N - - - - 
DQI#90 Extent to which commissioners work to meet needs of patients 
for complementary therapies where there is evidence to support 
their use. As a minimum, high quality information should be made 
available to patients about complementary therapies and 
services 
9 (2) Y 4 (3) 8 Y (82)  
Core 
DQI#91 Extent to which providers ensure practitioners delivering 
complementary therapies conforms to policies designed to 
ensure best practice  
9 (2) Y 8 (2) 7.5 Y (82) Core  
DQI#92 Extent to which commissioners institute mechanisms to ensure 
patient needs for rehabilitation are met and that services and 
8.5 (2) Y 8.5 (3) 8.5 Y (91) Core 
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suitable equipment are available to patients in all care locations  
 Information and communication with patients, carers and 
family 
      
DQI#93 Number of patients who indicate that they receive 
understandable explanations 
9 (1) Y 4.5 (6) 7.5 N (45) Supplementary 
DQI#94 Number of patients with documentation concerning the desired 
care and treatment  
8.5 (4) Y 5 (3) 8 Y (73) Core 
DQI#95 Extent to which patients feel able to communicate their needs in 
the best possible way, whether verbally or non-verbally 
5 (4) Y 3 (3) 3 N (45) - 
DQI#96 Extent to which patients feel they are provided with enough 
information to understand their illness and treatment 
9 (2) Y 3 (2) 7.5 Y (64) - 
DQI#97 Extent to which patients feel they are given bad news in a 
sensitive way 
5 (4) Y 4.5 (5) 4 N (36) Supplementary 
DQI#98 Number of patients with a holistic assessment of palliative care 
needs of patients and their family caregivers (e.g. SPARC) 
9 (2) Y 4 (4) 8.5 N (36) Supplementary 
DQI#99 Extent to which, according to the direct relatives, attention was 
paid to their own psychosocial and spiritual well-being 
1 (8) N - - - - 
DQI#100 Extent to which the direct relatives felt that they were treated well 
in all respects by the caregivers 
2 (8) N - - - - 
DQI#101 Extent to which direct relatives received information that was 
understandable and unambiguous 
1.5 (8) N - - - - 
DQI#102 Extent to which direct relatives received information about the 
advantages and disadvantages of various types of treatment 
1 (8) N - - - - 
DQI#103 Extent to which patients feel that specialists show an interest in 
you as a person  
1.5 (8) N - - - - 
DQI#104 Extent to which family and friends had opportunities to ask 
questions 
4 (5) N 3.5 (4) 2 N (36) - 
DQI#105 Extent to which patients feel they have the knowledge and 
support to make decisions 
8 (2) Y 3 (2) 8.5 Y (73) - 
DQI#106 Extent to which patients feel that they have opportunities to ask 
questions  
8 (1) Y 5.5 (2) 4.5 Y (64) Core  
DQI#107 Number of patients and family/caregivers that understand and 
are satisfied with provider communication about prognosis 
2 (8) N - - - - 
DQI#108 Extent to which patients are satisfied with their involvement in 
decision making  
9 (2) Y 8 (3) 8 Y (73) Core  
 Care planning, goal setting and shared decision making with 
patients, carers and family 
       
DQI#109 Number of patients with documentation of initial assessment 
completed within [x] week[s] from referral 
8.5 (4) Y 7.5 (3) 8.5 Y (64) Core 
DQI#110 Number of patients with regular patient and family care 
conferences with interdisciplinary team to discuss goals of care 
and care planning   
2 (8) N - - - - 
DQI#111 Number of patients with documentation of converted treatment 
goals into medical orders transferable across settings, for 
example, through Physician Orders for Life-Sustaining Treatment 
(POLST) program) 
1 (8) N - - - - 
DQI#112 Number of patients with advance directives and surrogacy 
designations available across settings using Internet-based 
registries or electronic personal health records  
8 (4) Y 7 (2) 8 Y (55) Core 
DQI#113 Number of patients with documentation of patient/surrogate 9 (3) Y 8 (2) 8 Y (91) Core 
Page 34 of 50
http://mc.http://mc.manuscriptcentral.com/palliative-medicine
Palliative Medicine
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
preferences for goals of care and treatment options at first 
assessment and at frequent intervals as conditions change 
DQI#114 Number of patients with documentation of involvement in 
decision-making over the past [x] months  
9 (3) Y 4.5 (6) 7.5 N (45) Supplementary 
DQI#115 Number of patients or caregiver(s) who received 1) 
comprehensive counselling regarding palliation and symptom 
management and end of life decisions 2) have advance care plan 
or surrogate decision maker in the medical record or 
documentation that patient did not wish or was not able to name 
a surrogate 
1 (8) N - - - - 
DQI#116 Number of patients and family/caregivers that understand and 
are satisfied with their participation in the development of 
treatment goals 
9 (3) Y 5 (4) 7.5 Y (55) Core 
 End of life care and decisions       
DQI#117 Number of patients with documentation of patient and family 
wishes about the care setting for the site of death, and fulfil 
patient and family preferences when possible  
1 (8) N - - - -  
DQI#118 Number of patients with adequate dosage of analgesics and 
sedatives as appropriate to achieve comfort during the active 
dying phase, and with addressed concerns and fears about using 
narcotics and of analgesics hastening death  
3 (6) N - - - - 
 Pre and post-bereavement support       
DQI#119 Number of patients with an assessment of psychological 
reactions of patients and families (including stress, anticipatory 
grief, and coping) in a regular, ongoing fashion in order to 
address emotional and functional impairment and loss 
3 (6) N - - - - 
DQI#120 Number of patients with a grief and bereavement care plan to 
provide services to patients and families prior to and for at least 
[x] months after the death of the patient  
3 (6) N - - - - 
DQI#121 Number of relatives offered counselling for survivors 3 (6) N - - - - 
DQI#122 Extent to which the hospice team kept family members informed 
about the patient’s condition (e.g. 
always/usually/sometimes/never) 
3 (6) N - - - - 
DQI#123 Number of relatives who received information from the team 
about the medicines that were used to manage the patient’s pain  
1.5 (8) N - - - -  
DQI#124 Number of relatives who received information from the team 
about what was being done to manage the patient’s trouble with 
breathing 
3 (8) N - - - - 
DQI#125 Number of patients where an immediate bereavement plan is 
activated post-death  
4 (8) N 3 (5) 1 N (0) -  
DQI#126  Number of relatives who indicate that the patient received 
support with preparations for saying goodbye 
2.5 (8) N - - - - 
 Co-ordination and continuity of care        
DQI#127 Number of patients with a professional caregiver nominated as 
the responsible ‘key worker‘ who coordinates care 
6 (4) Y 2.5 (4) 2.5 N (36) -    
DQI#128 Number of patients with a regular review of the care plan based 
on a comprehensive interdisciplinary assessment of the values, 
preferences, goals, and needs of the patient and family 
9 (1) Y 7.5 (2) 8 Y (91) Core 
DQI#129 The extent to which care plans are broadly disseminated to all 
professionals involved in the patient’s care 
9 (2) Y 7 (4) 8 Y (64) Core 
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DQI#130 The extent to which treatments that are no longer helpful are 
stopped  
4 (5) N 1 (4) 2 N (9) - 
DQI#131 The extent to which palliative care services are integrated into 
the local area health authority and operate at the specific request 
of the GP and in association with him/her 
1 (8) N  
- 
 
- 
 
- 
 
- 
DQI#132 While under the care of hospice, was there always one nurse 
who was identified as being in charge of the patient’s overall 
care? (yes/no) 
3 (8) N - - - - 
DQI#133 Was there any problem with hospice doctors or nurses not 
knowing enough about the patient’s medical history to provide 
the best possible care? (yes/no)  
1 (8) N  
- 
 
- 
 
- 
 
-  
DQI#134 Time from referral to first contact [calculated as the time in days 
between the referral date and the date of first contact or episode 
start date (whichever occurs first)] calculated for all episodes of 
care and across all settings of care 
7 (3) Y 8.5 (4) 7 Y (91) Core 
DQI#135 Number of patients with documentation of letter to the referring 
physician contains the following components:  diagnosis; 
conclusions concerning the care needs of the patient and 
caregiver(s); medical treatment plan; non-medical treatment plan; 
advice concerning driving aptitude; care advice for the patent and 
the caregiver(s) 
9 (5) N 7.5 (3) 8 Y (100) Core 
DQI#136 Number of patients with a care plan that is revisited with patient 
and family on a regular basis and following any significant 
change in health condition 
9 (2) Y 8 (4) 8 Y (64) Core 
 Structure and process of care       
DQI#137 Number of patients with documentation of a regular 
interdisciplinary/multi-professional meeting to discuss 
management  
9 (2) Y 7 (3) 8 Y (100) Core 
DQI#138 Number of patients provided with documentation on important 
complaints that can occur after primary treatment and can be a 
sign of disease progression 
1 (8) N - -  
- 
 
- 
DQI#139 Number of patients provided with sufficient time and attention 
during appointments and after primary treatment has finished 
2 (8) N - - - - 
DQI#140 Number of patients with a palliative care clinical record containing 
evidence of: Ethical, legal aspects of care 
1.5 (7) N -  - - - 
DQI#141 Number of patients with a palliative care clinical record containing 
evidence of: Clinical summary 
9 (2) Y 8 (2) 8 Y (91) Core 
DQI#142 Number of patients with a palliative care clinical record containing 
evidence of: Spiritual, religious, existential aspects of care  
8 (2) Y 8 (3) 8 N (36) Supplementary 
DQI#143 Number of patients with a palliative care clinical record containing 
evidence of: Physical aspects of care 
8 (2) Y 8.5 (4) 8 N (45) Supplementary 
DQI#144 Number of patients with a palliative care clinical record containing 
evidence of: Follow up assessment 
9 (2) Y 7.5 (6) 8 N (36) Supplementary 
DQI#145 Number of patients with a palliative care clinical record containing 
evidence of: Psychological and psychiatric aspects of care 
9 (3) Y 7.5 (4) 8 N (36) Supplementary 
DQI#146 Number of patients with evidence that the care plan was 
implemented by all providers consistent with goals of care 
1 (7) Y - - - - 
 Evidence of effectiveness, outcome assessment and 
measurement 
      
DQI#147 Number of patients where a validated tool used to monitor 7 (3) N 8.5 (4) 8 Y (64) Core  
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progress (e.g. Edmonton Symptom Assessment System, 
Edmonton Functional Assessment Tool, Part A of the McGill 
Quality of Life Index or the Palliative Care Problem Severity 
Scale) 
DQI#148 Evidence that the palliative care service is involved in research in 
palliative care (e.g. authorship of publications, research grants)  
1 (8) Y - - - - 
DQI#149 Number of non-oncological patients receiving palliative care 4 (5) Y 6.5 (7) 1 N (9) - 
DQI#150 Number of patients with documentation of adverse events 9 (2) Y 7.5 (4) 7 N (45) Supplementary 
DQI#151 Number of patients with evidence of a documented procedure to 
analyse and follow up adverse events 
9 (2) N 7.5 (4) 7 N (45) Supplementary 
DQI#152 Number of patients aware of patient complaint procedures 4 (6) Y 3.5 (7) 4 N (18) Supplementary 
DQI#153 Number of patients where a patient-reported outcome measures 
(PROMs) is used that has been validated with relevant 
populations requiring palliative care and which are sufficiently 
brief and straightforward and that they allow for proxy reports to 
be collected when the patient is unable to self-report 
7 (5) N 7 (8) 8 N (9) Supplementary 
DQI#154 Number of assessment using outcome measures to assess the 
needs of unpaid caregivers (family and others) alongside the 
needs of patients 
2.5 (8) N - - - - 
DQI#155 Evidence of use of change management principles, facilitation 
and communication to embed outcome measurement into routine 
clinical practice and evaluate the implementation process to 
ensure sustained use that penetrates practice within the 
organisation 
3 (8) Y - - - - 
DQI#156 Evidence of use of quality improvement systems to sustain 
routine practice of outcome measurement and institute 
interoperable electronic systems to ensure integration of 
measures  
3 (7) N - - - - 
DQI#157 Evidence of use of established national and international 
outcome collaborations that work towards benchmarking to 
establish and improve care standards 
1 (6) Y - - - - 
DQI#158 Evidence of use of monitoring of palliative care practice through 
routine collection of outcome data used to establish a minimum 
dataset of palliative care outcome measures in order to improve 
and advance care  
 
6 (4) 
Y 7 (4) 7 N (36) Supplementary 
 Staff training and education, service and professional 
development 
      
DQI#159 Number of staff who receive a standardised induction training 
within [x] month[s] of employment  
9 (2) Y 3 (5) 4 N (9) - 
DQI#160 All health and social care professionals have standardised 
learning objectives for continuing basic training in palliative care 
4 (5) Y 4 (4) 1.5 N (0) - 
DQI#161 Number of staff who professionally deal with loss with access to 
a program for care for the carers 
1.5 (8) N - - - - 
DQI#162 Number of staff assessed for satisfaction with working in the 
team (e.g. Team Climate Inventory) 
7 (6) Y 6.5 (4) 1 Y (55) - 
DQI#163 Documentation of processes in place to identify the training 
needs of all workers (registered and unregistered) that take into 
account the four core common requirements for workforce 
development (communication skills, assessment and care 
planning, advance care planning, and symptom management) as 
9 (3) Y 4.5 (4) 8 N (27) Supplementary 
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they apply to end of life care 
DQI#164 Number of staff with access to curricula for training as part of 
continuing professional education including palliative care for 
patients with illness other than cancer  
7 (6) Y 7.5 (3) 7.5 Y (64) Core 
 Access to services and service environment       
DQI#165 Number of patients who have access to diagnostic investigations 
(e.g. x-rays, blood samples] regardless of the setting 
1 (8) Y - - - - 
DQI#166 Number of patients receiving palliative care provided with 
transportation to the service 
1 (8) Y - - - - 
DQI#167 Number of patients experiencing a crisis where the following is 
arranged within [x] hours: admission 
1.5 (7) Y - - - - 
DQI#168 Number of patients receiving the following treatments as needed 
24 hours a day, [x] days a week: opioids and other controlled 
drugs 
8 (2) N 3.5 (7) 4 N (18) Supplementary 
DQI#169 There is a dedicated room where multidisciplinary team meetings 
within one setting takes place 
3 (7) N - - - - 
DQI#170 Relevant services and care providers should ensure equal 
access to available day services based on need through 
appropriate referrals 
9 (2) N 3 (5) 9 N (45) - 
DQI#171 All service users should have equity of access to all day services 
and support that is available 
3 (6) N - - - - 
DQI#172 If a confidential discussion has to take place then it should take 
place in private 
1.5 (8) Y - - - - 
DQI#173 The setting of care should meet the preferences, needs, and 
circumstances of the patient and family to the extent possible 
8.5 (4) N 4.5 (4) 4.5 Y (82) Core 
DQI#174 In rural areas where accessing specialized care is difficult, 
organizations should institute telehealth and telemedicine 
communications 
4 (6) Y 3.5 (4) 3 N (0) - 
 Promotion of effective external engagement       
DQI#175 Number of patients provided with access to an up to date 
directory of local caregivers and organisations  
1 (8) N - - - - 
DQI#176 Number of patients provided with access to dedicated information 
about the palliative care service: A website  
8 (6) Y 7 (3) 5 Y (82) Core 
DQI#177 Number of patients provided with access to dedicated information 
about the palliative care service: Leaflets or brochures  
9 (7) Y 6.5 (3) 7 Y (91) Core 
DQI#178 Develop healthcare and community collaborations to promote 
advance care planning and the completion of advance directives 
for all individuals(for example, the Respecting Choices and 
Community Conversations on Compassionate Care programs)  
 
8.5 (4) 
Y 8.5 (3) 7 Y (82) Core 
DQI#179 Processes will be in place to manage ethical aspects involving 
discordant patient, family, and caregiver goals and to handle 
disputes and uncertainties regarding a patient’s previously stated 
preferences and current family or proxy decisions. 
8 (7) Y 5 (5) 9 Y (55) Core 
 Societal, ethical and legal aspects of care        
DQI#180 Number of patients with documentation of informed consent 
before therapy  
9 (4) Y 8 (4) 9 Y (91) Core 
DQI#181 Annual reports are produced reporting the activities and 
characteristics of the service such as team composition, staff 
composition, resources, referring physicians, patient 
characteristics 
4 (3) Y 1.5 (8) 3 N (0) - 
Page 38 of 50
http://mc.http://mc.manuscriptcentral.com/palliative-medicine
Palliative Medicine
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
DQI#182 All patients living in psychosocial circumstances presenting a 
high-risk for their health should be identified as soon as possible  
3 (2) Y - - - - 
*Median Appropriateness Score /9 (Range): Appropriateness ratings of 1-3 were categorized as inappropriate, ratings of 4-6 were classified as uncertain and ratings 7-9 were classified as 
appropriate.   
†Agreement between panel Y/N: With a panel size of 16, level of agreement was based on a maximum of four panel members rating a quality indicator outside a three-point region around the 
median value; with disagreement defined as five or more panel members rating an indicator at the extreme ends of the scale as either inappropriate (1-3) or appropriate (7-9).  
§Median Feasibility Score /9: Feasibility was assessed using the same 9 point scale as appropriateness, and level of agreement was based on a maximum of three panel members rating a 
quality indicator outside a three-point region around the median value; with disagreement defined as four or more panel members rating an indicator at the extreme ends of the scale as either 
inappropriate (1-3) or appropriate (7-9). Level of agreement data for feasibility are not shown  
¶Rated as necessary by panel members Y/N (% yes). 
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Supplementary file 2: Derivation of final indicator set (n=30) from original candidate indicators, including indicators combined during RAM round 3   
 Final indicator description following phase three of RAND/UCLA Appropriateness Method  
 
Original (combined) 
candidate indicators 
 A. Physical care and support, assessment and treatment   
A1 Proportion of service users with assessment of pain severity at screening using a valid measure   #01 
A2 Proportion of service users with moderate or severe pain assessed to explore possible causes of pain   #03,#10,#11 
A3 Proportion of service users with assessment of breathlessness at screening using a valid measure  #12 
A4 Proportion of service users with assessment of fatigue at screening using a valid measure  #24 
A5 Proportion of service users with assessment of functional status to identify daily activity limitations completed before a multidisciplinary care plan   #30 
 B. Psychological care and support, assessment and treatment  
B6 Proportion of service users screened for depression at screening using a valid measure   #38 
B7 Proportion of service users screened for anxiety at screening using a valid measure   #41 
B8 Proportion of service users with assessment of cognitive functioning  #55 
 C. Spiritual and emotional care and support  
C9 Proportion of service users with documentation of a spiritual aspects of care discussion or assessment completed before a multidisciplinary care 
plan      
#68;#71  
 D. Information and Communication with Service Users  
D10 Proportion of service users who report that they are provided with sufficient, appropriately tailored information or advice on their condition and on 
intervention options to support decisions on agreed care planning 
#177,#179 
 E. Co-ordination and continuity of care  
E11 Proportion of service users with a comprehensive needs assessment completed before a multidisciplinary care plan to identify main symptoms 
and concerns and their effect     
#59,#85,#109 
E12 Service has a written care pathway for assessment and management of moderate or severe pain including appropriate onward referral routes #10,#11 
E13 Proportion of service users with documentation of re-assessment at regular review in line with time points agreed in the multidisciplinary care 
plan 
#128,#136,#137,#147 
E14 Service has a written standard operating procedure defining timeframes for time to initial contact, completion of needs assessment and 
multidisciplinary care plan 
#33, #94 
E15 Proportion of service users with documentation of appropriate intervention in line with the agreed, multidisciplinary care plan      #39, #70, #76   
E16 Proportion of service users with documented communication between the service and the General Practitioner providing information on care 
needs and the agreed care plans   
#77,#135 
E17 Proportion of service users with a care plan available as specified by the service’s written standard operating procedure for development and 
usage of multidisciplinary care plans 
#129,#141 
E18 Proportion of service users with documented evidence of being offered the opportunity for completion of advance care planning   #178 
E19 Proportion of service users with quality of life assessed using a valid measure at screening and at regular review in line with time points agreed in 
the multidisciplinary care plan   
#51 
 F. Care planning, goal setting and shared decision making with service users  
F20 Service has a written standard operating procedure for development and usage of multidisciplinary care plans #109 
F21 Proportion of service users with documentation of main care goals in the multidisciplinary care plan                                                                                                                                                                 #32,#33,#45,#69,#94,#113
 G. Evidence of effectiveness, outcome assessment and measurement  
G22 Service has a written policy for reviewing and updating standard operating procedures and care pathways  
G23 Proportion of service users re-assessed at regular review who report that main care goals are met in line with the multidisciplinary care plan #14,#26,#29,#40 
G24 
G25 
Proportion of service users with assessment of satisfaction with overall care and support performed using a valid measure 
Proportion of service users with assessment of satisfaction with involvement in shared decision making    
#37 
#106, #108, #116 
 H. Staff training and education, service and professional development  
H26 Extent to which staff have access to training around core components of care as part of continuing education and personal development #164 
 I. Access to services and service environment  
I27 Proportion of service users with a record of time in days from referral date to first attendance date offered by service  #134 
I28 The service provides suitable equipment and settings to deliver care #92,#173 
I29 Service has a written policy for defining standards for equipment and settings which are available for delivery of care #92 
 J. Societal, ethical and legal aspects of care  
J30 Number of service users with correctly completed documentation of informed consent to treatment or medical intervention    #180 
Page 40 of 50
http://mc.http://mc.manuscriptcentral.com/palliative-medicine
Palliative Medicine
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
 
Page 41 of 50
http://mc.http://mc.manuscriptcentral.com/palliative-medicine
Palliative Medicine
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
Supplementary file 3: Extract from the QualPalUK toolkit, showing data extraction required for quality indicator A1 (Proportion of service users with 
assessment of pain severity at screening using a valid measure) 
 
LOGO PALLIATIVE DAY SERVICE QUALITY INDICATOR SET:  
DATA ABSTRACTION FORM A [PATIENT LEVEL 
INDICATORS]  
ABSTRACTOR: 
  
 
DATE:   SITE:  
 
 
       
DATA SAMPLE & REFERENCE PERIOD: e.g.  15 consecutive service users discharged in period (INSERT DATES)  
QI DENOMINATOR  Please use table to abstract the required information from each clinical record 
# Assessment 
documented 
Assessment 
during 
screening 
Valid 
Measure  
used  
State measure 
used 
Comments 
1          
2         
3         
4         
5         
6         
7         
8         
9         
10         
11         
12         
13         
14         
15         
 
A1 Number of sample attending day hospice during reference period     N=15 
NUMERATOR  
Number of service users with assessment of pain severity at screening using a valid 
measure 
- 
Required criteria: 
 Pain severity assessment documented in notes  
 Pain severity assessed completed during screening [within 1-3 visits] 
 Pain severity assessed using a valid measure   
Key terms/definitions: 
• Service users: Patients attending day hospice  
• Pain severity: Unidimensional assessment of current pain level using a valid measure and 
accepted descriptors of pain severity or intensity (e.g., Pain Visual Analogue Scale (VAS), Pain 
Numerical Rating scale (NRS) or Pain Verbal Rating Scale (VRS)** 
• Screening: Processes of assessment undertaken during the early stages (within 1-3 visits) of 
attendance at day service, at triage, or at the beginning of a new episode or phase of care     
• Valid measure: The measure is appropriate and has acceptable validity and reliability when 
used according to specific instructions 
 
** Observational or other non, self-reported measures are not included in assessment of this 
indicator   
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Recommendations for the Conducting and REporting of DElphi Studies (CREDES)* 
CREDES Recommendation Yes 
/No 
Authors’ comments 
1. Justification The choice of the Delphi technique as a method of systematically 
collating expert consultation and building consensus needs to be well 
justified. When selecting the method to answer a particular research 
question, it is important to keep in mind its constructivist nature 
 RAND UCLA method (modified Delphi 
technique) has been justified (p4) 
2. Planning and 
process 
The Delphi technique is a flexible method and can be adjusted to the 
respective research aims and purposes. Any modifications should be 
justified by a rationale and be applied systematically and rigorously 
 The RAND/UCLA method is a modified Delphi 
technique. We have used the method 
specified in the RAND/UCLA manual[6] (p4) 
3. Definition of 
consensus 
Unless not reasonable due to the explorative nature of the study, an a 
priori criterion for consensus should be defined. This includes a clear 
and transparent guide for action on (a) how to proceed with certain 
items or topics in the next survey round, (b) the required threshold to 
terminate the Delphi process and (c) procedures to be followed when 
consensus is (not) reached after one or more ite ations 
 The RAND/UCLA method does not require 
consensus. There are however predefined 
criteria for selection of items to proceed in 
the next round, which we have adhered to. 
These are specified on pp 7-9. 
4. Informational 
input 
All material provided to the expert panel at the outset of the project 
and throughout the Delphi process should be carefully reviewed and 
piloted in advance in order to examine the effect on experts’ 
judgements and to prevent bias 
 All materials provided to the expert panel, 
including the evidence tables, instructions, 
and ratings forms were reviewed by both the 
research team (which includes palliative care 
clinicians) and two end user representatives. 
(p8) 
5.  Prevention of 
bias 
Researchers need to take measures to avoid directly or indirectly 
influencing the experts’ judgements. If one or more members of the 
research team have a conflict of interest, entrusting an independent 
researcher with the main coordination of the Delphi study is advisable 
 Researchers involved with the coordination 
of the RAND/UCLA process had no conflicts 
of interest. The expert ratings (judgements) 
were all completed independently. 
Standardised instructions were provided to 
panellists. (p8) 
6. Interpretation 
and processing of 
results 
Consensus does not necessarily imply the ‘correct’ answer or 
judgement; (non)consensus and stable disagreement provide 
informative insights and highlight differences in perspectives 
concerning the topic in question 
 As in 3 above, consensus is not required for 
the RAND/UCLA process. However, there are 
predefined criteria for ‘agreement’ about the 
appropriateness and feasibility of individual 
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items. Agreement (or lack of agreement) on 
individual items is provided in supplementary 
file 1. 
7. External 
validation 
It is recommended to have the final draft of the resulting guidance on 
best practice in palliative care reviewed and approved by an external 
board or authority before publication and dissemination 
 The development of the indicators was 
funded, and endorsed by Marie Curie (UK 
palliative care provider). In response to 
feedback from end users we are currently 
developing an electronic version of the 
toolkit, and have sought funding to support 
the implementation of the toolkit in UK 
palliative day services. We will seek 
validation for the electronic quality indicator 
toolkit from palliative care organisations and 
care providers.  
8. Purpose and 
rationale 
The purpose of the study should be clearly defined and demonstrate 
the appropriateness of the use of the Delphi technique as a method to 
achieve the research aim. A rationale for the choice of the Delphi 
technique as the most suitable method needs to be provided 
 The purpose of the study and the 
appropriateness of the RAND/UCLA method 
(modified Delphi technique) is clearly defined 
on p 4. 
9. Expert panel Criteria for the selection of experts and transparent information on 
recruitment of the expert panel, sociodemographic details including 
information on expertise regarding the topic in question, 
(non)response and response rates over the ongoing iterations should 
be reported 
 Criteria for the selection of experts and 
information on recruitment of expert panel 
members is provided on p7, including a 
summary of the professional background and 
expertise of panel members.  
10. Description of 
the methods 
The methods employed need to be comprehensible; this includes 
information on preparatory steps (How was available evidence on the 
topic in question synthesised?), piloting of material and survey 
instruments, design of the survey instrument(s), the number and 
design of survey rounds, methods of data analysis, processing and 
synthesis of experts’ responses to inform the subsequent survey round 
and methodological decisions taken by the research team throughout 
the process 
 The methods have been described in detail, 
and are informed by the processes, steps, 
and criteria specified in the RAND/UCLA 
manual[6]. The survey instruments (rating 
forms) are also adapted from the 
RAND/UCLA manual. The number and design 
of rounds, methods of data analysis and 
decision-making re items are described, and 
adapted from the RAND/UCLA manual[6].  
11. Procedure Flow chart to illustrate the stages of the Delphi process, including a  A flowchart detailing the phases of the 
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preparatory phase, the actual ‘Delphi rounds’, interim steps of data 
processing and analysis, and concluding steps 
research, including the RAND/UCLA rounds, 
and the results at each stage is provided. 
12. Definition and 
attainment of 
consensus 
It needs to be comprehensible to the reader how consensus was 
achieved throughout the process, including strategies to deal with non-
consensus 
 As in 3 above, consensus is not required. We 
have however described how decisions were 
made about the progression of items 
between rounds.  
13. Results Reporting of results for each round separately is highly advisable in 
order to make the evolving of consensus over the rounds transparent. 
This includes figures showing the average group response, changes 
between rounds, as well as any modifications of the survey instrument 
such as deletion, addition or modification of survey items based on 
previous rounds 
 We have reported the results of each round 
separately. Supplementary file 1 provides a 
detailed description of the scores for each 
individual item at round 1 (including median 
appropriateness scores and agreement), and 
at round 2 (including median 
appropriateness and feasibility scores, and 
necessity ratings). Supplementary file 2 
provides details of indicators combined at 
round 3. 
14. Discussion of 
limitations 
Reporting should include a critical reflection of potential limitations 
and their impact of the resulting guidance 
 A critical summary of limitations is provided 
in the discussion section (p18) 
15. Adequacy of 
conclusions 
The conclusions should adequately reflect the outcomes of the Delphi 
study with a view to the scope and applicability of the resulting 
practice guidance 
 The conclusions reflect the results of the 
RAND study. We have commented on scope 
and applicability of the indicators, including 
further work required. (p15-17) 
16. Publication and 
dissemination 
The resulting guidance on good practice in palliative care should be 
clearly identifiable from the publication, including recommendations 
for transfer into practice and implementation. If the publication does 
not allow for a detailed presentation of either the resulting practice 
guidance or the methodological features of the applied Delphi 
technique, or both, reference to a more detailed presentation 
elsewhere should be made (e.g. availability of the full guideline from 
the authors or online; publication of a separate paper reporting on 
methodological details and particularities of the process (e.g. 
persistent disagreement and controversy on certain issues)). A 
dissemination plan should include endorsement of the guidance by 
 The final indicator set is provided within the 
publication (table 1). The authors can be 
contacted for a copy of the toolkit used to 
abstract data relevant to the indicator set. An 
abstract of the toolkit is provided in 
supplementary file 3. As described on pp 17-
18 we are, in response to feedback from 
users, currently developing an electronic 
version of the indicator toolkit which will be 
subsequently assessed for feasibility and 
appropriateness in practice. We will seek 
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professional associations and health care authorities to facilitate 
implementation 
endorsement from palliative care 
organisations for the final electronic toolkit, 
and will work in collaboration with these 
organisations to implement use of the 
indicators in palliative day services 
throughout the UK. 
*reproduced from: Junger S, Payne SA, Brine J, et al. Guidance on Conducting and REporting DElphi Studies (CREDES) in palliative care: Recommendations 
based on a methodological systematic review. Palliat Med 2017;31:684-706. 
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PALLIATIVE MEDICINE AUTHOR SUBMISSION CHECKLIST   
Please complete this checklist for all papers submitted. Please indicate, very briefly, how this has been addressed. This checklist is a 
mandatory upload on submission.  
Item Explanation How this has been addressed 
(briefly, a sentence will suffice) 
 
Article title WHY: Because we want readers to find your work. 
Have you followed our guidelines on writing a good title that will be found by search engines? (E.g. with 
methods in the title, use of common words for the issue addressed, no country names, and possibly 
indicating findings). If your study has an acronym is it included in the title? 
 
Yes. We have included key terms 
and method (modified Delphi 
Technique). 
Abstract WHY: Because structured abstracts have more detail for readers and search engines. 
Have you followed our guidelines on writing your structured abstract? Please remember we have 
separate abstract structures for original research, reviews and case reports. There should be no 
abbreviations in the abstract, EXCEPT a study acronym which should be included if you have one. If a trial 
(or other design formally registered with a database) have you included your registration details? 
 
We have included a structured 
research abstract. We have 
combined the sub-headings 
‘design’ and ‘setting’, as we 
believe this to be more 
appropriate and concise for our 
study characteristics. 
Key statements WHY: Because readers want to understand your paper quickly. 
Have you included our key statements within the body of your paper (after abstract and before the main 
text is a good place!) and followed our guidelines for how these are to be written?   There are three main 
headings required, and each may have 1-3 separate bullet points. Please use clear, succinct, single 
sentence separate bullet points rather than complex or multiple sentences.  
 
We have included several clear 
succinct statements under each 
of the 3 headings. 
Keywords WHY: Because MeSH headings mean it is properly indexed. 
Have you given keywords for your study? We ask that these are current MeSH headings unless there is 
no suitable heading for use (please give explanation in cover letter).  https://meshb.nlm.nih.gov/search  
 
We have included 5 current 
MeSH headings. 
International 
relevance 
WHY: We have readers from around the world who are interested in your work.  
Have you contextualised your work for an international audience and explained how your work 
contributes to an international knowledge base?  Avoid drawing from policy from one context only, think 
We have explained that our 
quality indicator set is relevant to 
palliative day internationally. We 
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how your work could be relevant more widely. Do define terms clearly e.g. hospice has a different 
meaning in many countries.  
 
have also provided the results of 
the international systematic 
scoping review (182 original 
indicators) which can be used by 
other jurisdictions to modify their 
indicators if necessary. 
Publishing 
guidelines 
WHY: Because clear and robust reporting helps people interpret your work accurately 
Have you submitted a completed checklist for a relevant publishing guideline as a supplementary file? 
http://www.equator-network.org/ These include CONSORT, PRISMA, COREQ checklists, but others may 
be more relevant for your type of manuscript. If no published checklist exists please create one as a table 
from the list of requirements in your chosen guideline. If your study design does not have a relevant 
publishing guideline please review closest matches and use the most appropriate with an explanation.  
 
There are no reporting guidelines 
for a RAND/UCLA 
appropriateness study 
specifically. However, as the 
RAND/UCLA method is a modified 
Delphi technique, we have used 
the Recommendations for the 
Conducting and REporting of 
DElphi Studies (CREDES), 
published in Pall Med and 
available via the EQUATOR 
website.   
Word count WHY: Because readers want to find the core information quickly. 
Does your paper adhere to our word count for your article type? Please insert number of words in the 
box to the right. Remember that tables, figures, qualitative data extracts and references are not included 
in the word count.  
 
Yes. Word count (excluding 
tables, figures, references and 
abstract) is 2999/3000. 
Figures and tables 
and/or quotations 
WHY: Because readers want to find the core information quickly.  
Have you adhered to our guidelines on the number of tables and figures for your article type?  
 
Data (e.g. quotations) for qualitative studies are not included in the word count, and we prefer that they 
are integrated into the text (e.g. not in a separate table).  
 
Yes. We have included 1 figure 
and 1 table in the main 
document, and additional 
information in 4 supplementary 
files. 
Study registration WHY: Because this means readers understand how you planned your study 
Where appropriate have you included details (including reference number, date of registration and URL) 
of study registration on a database e.g. trials or review database. If your study has a published protocol, 
is this referenced within the paper?  
n/a 
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Other study 
publications? 
WHY: So readers can understand the full context of your study 
If there are other publications from this study are these referenced within the body of the paper? Please 
do not reference papers in preparation or submitted, but in-press publications are acceptable.  
 
We have referenced the 
published protocol of the scoping 
review - which produced the 
original candidate quality 
indicators used in the study.  
Scales, measures or 
questionnaires 
WHY: So readers can understand your paper in the context of this information 
If your study primarily reports the development or testing of scales/measures or questionnaires have 
you included a copy of the instrument as a supplementary file?  
 
We have developed a set of 30 
quality indicators, which are 
provided within the main 
document. We have also 
provided an extract of the data 
extraction toolkit as a 
supplementary file, and detailed 
contact information for parties 
interested in using the toolkit. 
Abbreviations WHY: Because abbreviations make a paper hard to read, and are easily misunderstood 
Have you removed all abbreviations from the text except for extremely well known, standard 
abbreviations (e.g. SI units), which should be spelt out in full first? We do not allow abbreviations for 
core concepts such as palliative or end of life care.  
 
There are no abbreviations in the 
text. 
Research ethics 
and governance 
approvals for 
research involving 
human subjects 
WHY: We will only publish ethically conducted research, approved by relevant bodies 
Have you given full details of ethics/governance/data protection approvals with reference numbers, full 
name of the committee(s) giving approval and the date of approval?  If such approvals are not required 
have you made it explicit within the paper why they were not required. Are details of consent 
procedures clear in the paper? 
 
Yes. These details are included in 
the text. 
Date(s) of data 
collection 
WHY: So readers understand the context within which data were collected 
Have you given the dates of data collection for your study within the body of your text? If your data are 
over 5 years old you will need to articulate clearly why they are still relevant and important to current 
practice.  
 
Yes. These details are included in 
the text. 
Structured 
discussion 
WHY: So readers can find key information quickly 
Papers should have a structured discussion, with sub headings, summarising the main findings, 
Yes. We have included a 
structured discussion. 
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addressing strengths and limitations, articulating what this study adds with reference to existing 
international literature, and presenting the implications for practice.  
 
Case reports WHY: So that participants are protected, and its importance made clear 
If your study is a case report have you followed our clear structure for a case report, including 
highlighting what research is needed to address the issue raised?  Have you made clear what consent 
was required or given for the publication of the case report? Have you provided evidence of such 
consent as a supplementary file to the editor?  
 
n/a 
Acknowledgements 
and declarations 
WHY: So readers understand the context of the research 
Have you included a funding declaration according to the SAGE format?  Are there acknowledgements to 
be made? Have you stated where data from the study are deposited and how they may be available to 
others? Have you conflicts of interest to declare? 
 
Funding declaration, 
acknowledgements and conflicts 
of interest are included. 
Additional data is available as a 
supplementary file. 
Supplementary 
data and materials 
WHY: So the context is clear, but the main paper succinct for the reader 
Is there any content which could be provided as supplementary data which would appear only in the 
online version of accepted papers? This could include large tables, full search strategies for reviews, 
additional data etc.  
Yes. There are 4 supplementary 
files, including two large table 
showing the derivation of the 
quality indicators, an extract from 
the data extraction toolkit, and 
results from the practice test. 
References WHY: So people can easily find work you have referenced 
Are your references provided in SAGE Vancouver style? You can download this style within Endnote and 
other referencing software. 
 
Yes. 
Ownership of 
work.  
Can you assert that you are submitting your original work, that you have the rights in the work, that you 
are submitting the work for first publication in the Journal and that it is not being considered for 
publication elsewhere and has not already been published elsewhere, and that you have obtained and 
can supply all necessary permissions for the reproduction of any copyright works not owned by you. 
 
Yes, I confirm this. 
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